In its "Global Automotive Mobility Study", experts from Arthur D. Little shed light on the three megatrends of autonomous driving: electric mobility and car sharing.
Disruptive innovations challenge pharma companies to change up business models and value chains to stay ahead. In this article, Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré and Richard Beetz of Arthur D. Little discuss how as the industry becomes more digitalized, pharma companies will need to implement changes that will ultimately lead to new business models and value chains.
Innovation from sources outside of the traditional healthcare system is changing the pharma industry. A digital revolution in many business models means a positive overall change for patient care - but introducing new services too quickly could see development in other areas suffering. In this article Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré and Richard Beetz from Arthur D. little discuss the impact of digital health on the pharmaceutical industry.
It is becoming clear that in order to stay relevant in the future healthcare ecosystem, pharma companies must look to business models that foster much more direct patient engagement than previously. New methods offer significant potential in increasing the quality and efficiency of care. In this article, Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré and Richard Beetz from Arthur D. Little explain how digital health solutions can solve the major long-term issues of pharma’s most important client groups – patients, providers and payers – all at the same time.
Innovation has always been one of the foundations for success in the pharmaceutical industry. While the sector has been very good at developing innovation from scratch or incremental innovation of existing products, it now faces an ultimately differently challenge - dealing with disruptive innovation that is driven by inventions outside the healthcare sector. New players from the digital arena are currently redefining the way the industry works. In this article, Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré and Richard Beetz of Arthur D. Little discuss how digital is reshaping the pharma arena.
The business model of the pharmaceutical industry is being transformed by digital health. It will significantly extend current business models, or even create completely new ones for the industry. In order to implement innovative solutions ahead of new entrants, pharma companies will need to undergo major transformation programs and convert three completely different value chains: pharma, medical devices for measuring health parameters, and IT solutions to process and connect data. In this article, Ulrica Sehlstedt, Nils Bohlin, Fredrik de Maré and Richard Beetz of Arthur D. Little discuss how pharma companies can get ahead of disruptive innovations and thrive in the digital world.
Investment in the digital healthcare space has never been greater than in 2015, and looks set to continue its upward trajectory in 2016. Healthcare delivery models are changing, placing empowered patients at the center of the traditional pharma ecosystem. Now pharma must fully embrace digital opportunities or risk losing a huge piece of its own future. In this article, a report from Arthur D. Little is quoted as saying that by 2020, the traditional pharma business model will be turned on its head.
Companies with new technologies and approaches are entering healthcare, and challenging pharma's traditional dominance in the sector. Today we are already seeing pharma companies such as Merck (through its patient engagement platform, Merckengage) and AbbVie (with a video solution for the management of Parkinson's Disease with Karolinska University Hospital) making initial steps towards offering a range of basic services that support important areas such as patient compliance, adherence or interdisciplinary collaboration. In this article, the authors explain why the world can expect many more innovations to be applied to healthcare by pharma companies.
This feature article is adapted from Arthur D. Little’s recent Viewpoint on ‘Embracing the Consumer Health Opportunity. Today’s technological landscape is completely different from the recent past. New generations of consumers use mobile technology as a natural extension of themselves. New technology is leading to changes in consumption patterns – in the retail world the role of the traditional store is changing as online and mobile shopping become more prevalent and different consumption modes overlap. Today’s consumers want the ability to buy when and where they want. Players in all areas of the healthcare industry can get ahead by adapting to the digital consumer.
This online feature article is adapted from Arthur D. Little’s recent Viewpoint on ‘Embracing the Consumer Health Opportunity. Over the course of the last decade the consumer health industry has risen as an important force that is reshaping the future of healthcare. It is enabling an individual-centric model whereby consumers play a more central and informed role alongside providers in healthcare prevention, maintenance and ultimately, treatment. There is enormous market potential in the cross-dimensional opportunity space. All players need to improve weak capabilities and leverage strengths. In the center, of course, is the consumer.